Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN)

Gynecologic Oncology

Volumn 115, Issue 2, 2009, Pages 262-266

  Dal Bello, Barbara ^a   Spinillo, Arsenio ^a   Alberizzi, Paola ^a   Cesari, Stefania ^a   Gardella, Barbara ^a   Silini, Enrico Maria ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Cervix; CIN; Genotypes; HPV; Molecular epidemiology; SIL

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 10; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 17; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 7; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN PAPILLOMAVIRUS TYPE 9; HUMAN TISSUE; INFECTION RATE; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 70349742223     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.07.029     Document Type: Article

References (41)

1. Human Papillomaviruses (2005), International Agency for Research on Cancer, Lyon, France
2. Trottier H., and Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 24 Suppl 1 (2006) S1-S15
3. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 Suppl 10 (2008) K1-K16
4. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl 3 (2006) S26-S34
5. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
6. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
7. Castle P.E., Jeronimo J., Schiffman M., Herrero R., Rodriguez A.C., Bratti M.C., et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res. 66 (2006) 1218-1224
8. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat. Rev. Cancer 6 (2006) 753-763
9. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 97 (2005) 1072-1079
10. Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J., et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37 (1999) 2508-2517
11. In: Tavassoli F.A., and Devilee P. (Eds). Pathology and Genetics of Tumours of the Breast and Female Genital Organs (2003), IARC Press, Lyon, France
12. Dal Bello B, Spinillo A, Alberizzi P, Cesari S, Gardella B, Silini EM. A validation study of the use of the SPF-10 LiPA HPV typing assay in formalin-fixed paraffin-embedded cervical biopsies. J Clin Microbiol 2009;47:2175-80.
13. van Doorn L.J., Molijn A., Kleter B., Quint W., and Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J. Clin. Microbiol. 44 (2006) 3292-3298
14. Karlsen F., Kalantari M., Chitemerere M., Johansson B., and Hagmar B. Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab. Invest. 71 (1994) 604-611
15. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
16. Sebbelov A.M., Davidson M., Kruger Kjaer S., Jensen H., Gregoire L., Hawkins I., et al. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes. Infect. 2 (2000) 121-126
17. Bertelsen B.I., Kugarajh K., Skar R., and Laerum O.D. HPV subtypes in cervical cancer biopsies between 1930 and 2004: detection using general primer pair PCR and sequencing. Virchows Arch. 449 (2006) 141-147
18. Gravitt P.E., van Doorn L.J., Quint W., Schiffman M., Hildesheim A., Glass A.G., et al. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J. Clin. Microbiol. 45 (2007) 3245-3250
19. Safaeian M., Herrero R., Hildesheim A., Quint W., Freer E., Van Doorn L.J., et al. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45 (2007) 1447-1454
20. Castle P.E., Gravitt P.E., Solomon D., Wheeler C.M., and Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J. Clin. Microbiol. 46 (2008) 109-117
21. Perrons C., Jelley R., Kleter B., Quint W., and Brink N. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32 (2005) 278-285
22. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153 (1998) 1731-1739
23. Baay M.F., Quint W.G., Koudstaal J., Hollema H., Duk J.M., Burger M.P., et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34 (1996) 745-747
24. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J. Clin. Microbiol. 44 (2006) 3122-3129
25. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J. Clin. Microbiol. 40 (2002) 979-983
26. Klug S.J., Molijn A., Schopp B., Holz B., Iftner A., Quint W., et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J. Med. Virol. 80 (2008) 1264-1274
27. Quint W.G., Scholte G., van Doorn L.J., Kleter B., Smits P.H., and Lindeman J. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping. J. Pathol. 194 (2001) 51-58
28. Castle P.E., Porras C., Quint W.G., Rodriguez A.C., Schiffman M., Gravitt P.E., et al. Comparison of two PCR-based human papillomavirus genotyping methods. J. Clin. Microbiol. 46 (2008) 3437-3445
29. Wheeler C.M., Hunt W.C., Joste N.E., Key C.R., Quint W.G., and Castle P.E. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J. Natl. Cancer Inst. 101 (2009) 475-487
30. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 (2003) 63-73
31. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., and Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1157-1164
32. Munoz N., Bosch F.X., Castellsague X., Diaz M., de Sanjose S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111 (2004) 278-285
33. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121 (2007) 621-632
34. Gonzalez C., Ortiz M., Canals J., Munoz L., Jarrin I., de la Hera M.G., et al. Higher prevalence of human papillomavirus infection in migrant women from Latin America in Spain. Sex Transm. Infect. 82 (2006) 260-262
35. Tornesello M.L., Duraturo M.L., Buonaguro L., Vallefuoco G., Piccoli R., Palmieri S., et al. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect. Agent Cancer 2 (2007) 1
36. Silini E., Bono F., Cividini A., Cerino A., Maccabruni A., Tinelli C., et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J. Hepatol. 22 (1995) 691-695
37. Laukkanen P., Koskela P., Pukkala E., Dillner J., Laara E., Knekt P., et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J. Gen. Virol. 84 (2003) 2105-2109
38. Peto J., Gilham C., Deacon J., Taylor C., Evans C., Binns W., et al. Cervical HPV infections and neoplasia in a large population-based prospective study: the Manchester cohort. Br. J. Cancer 91 (2004) 942-953
39. Dillner J. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection. J. Clin. Virol. 19 (2000) 7-23
40. Clifford G.M., Goncalves M.A., and Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 20 (2006) 2337-2344
41. Luque A.E., Jabeen M., Messing S., Lane C.A., Demeter L.M., Rose R.C., et al. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J. Infect. Dis. 194 (2006) 428-434